It's not recommended to open the capsules, as they are designed to be swallowed whole
In the new guidance documents, FDA allows new regulatory flexibility for certain sensor-based wearable products and defines a new category of enforcement discretion for CDS products that provide only one option. Further changes are expected in 2026, with CDRH planning to release an updated policy for device software functions all part of Makarys goal to make the agencys digital health guidance documents shorter by about 50% or more and make them more clear, more concise, more modern, and more consistent. The FDA is also operating a pilot program in collaboration with the Centers for Medicare and Medicaid Services called TEMPO
Patients who want a baseline panel for their own reasons will need to arrange that through their primary care clinician or a third-party at-home testing service
Tolerability and side effects : Common adverse effects include nausea, vomiting, diarrhoea, and constipation, which typically improve over time
Recreational athletes not subject to testing can use both modalities
Strategies to overcome plateaus include increasing physical activity, refining your diet macronutrients, improving sleep, orif clinically appropriateexploring PlexusDx's GLP-Squared dual-compound option combining semaglutide and tirzepatide for additive weight loss signals
